SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Investment: Ferroptosis Modulation Investment Landscape

investment 1,087 words KG: ferroptosis 2026-03-24

kind:investment section:unclassified state:published

Contents

Ferroptosis Modulation Investment Landscape

Knowledge Graph

Related Hypotheses (30)

ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro
Score: 0.66 Purinergic Signaling Polarization Control
Score: 0.55 Mechanosensitive Ion Channel Reprogramming
Score: 0.51 Lipid Droplet Dynamics as Phenotype Switches
Score: 0.46 Ferroptosis Inhibition for α-Synuclein Neuroprotection
Score: 0.55

Senescence-Induced Lipid Peroxidation Spreading
Score: 0.53 Circadian-Gated Maresin Biosynthesis Amplification
Score: 0.47 Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th
Score: 0.45 Mitochondrial SPM Synthesis Platform Engineering
Score: 0.38 SASP-Mediated Complement Cascade Amplification
Score: 0.70 Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.67 Transcriptional Autophagy-Lysosome Coupling
Score: 0.66 Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65 CYP46A1 Overexpression Gene Therapy
Score: 0.63 Circadian Glymphatic Entrainment via Targeted Orexin Recepto
Score: 0.62 APOE-Dependent Autophagy Restoration
Score: 0.61 Digital Twin-Guided Metabolic Reprogramming
Score: 0.61 Senescence-Activated NAD+ Depletion Rescue
Score: 0.60 Multi-Modal Stress Response Harmonization
Score: 0.60 Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59 Circadian-Synchronized Proteostasis Enhancement
Score: 0.58 Microbial Inflammasome Priming Prevention
Score: 0.58 PARP1 Inhibition Therapy
Score: 0.58 AMPK hypersensitivity in astrocytes creates enhanced mitocho
Score: 0.57 Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.57 Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57 SASP-Mediated Cholinergic Synapse Disruption
Score: 0.56 Selective HDAC3 Inhibition with Cognitive Enhancement
Score: 0.56 Smartphone-Detected Motor Variability Correction
Score: 0.56

Related Analyses (30)

4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived

APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived Epigenetic reprogramming in aging neurons
neurodegeneration · archived Extracellular vesicle biomarkers for early AD detection
neurodegeneration · completed Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived Senescent cell clearance as neurodegeneration therapy
neurodegeneration · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived Gene expression changes in aging mouse brain predicting neur
neurodegeneration · completed SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived Circuit-level neural dynamics in neurodegeneration
neuroscience · archived Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived

Related Experiments (9)

Down Syndrome Alzheimer's Disease: Mechanisms and Therapeuti
clinical · proposed · Score: 0.40 ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 Ferroptosis Validation in Parkinson's Disease
clinical · proposed · Score: 0.40 Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel
validation · proposed · Score: 0.40 S-equol-induced ferroptosis mechanism in TNBC cells
exploratory · proposed · Score: 0.90

Gandouling protection against brain injury in Wilson's disea
validation · proposed · Score: 0.90 Proposed experiment from debate on Microglia activate astroc
falsification · proposed · Score: 0.40 Proposed experiment from debate on Microglia activate astroc
falsification · proposed · Score: 0.40 Peroxisome Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.40

See Also (15)

ACSL4 Gene - Acyl-CoA Synthetase Long Chain Family Memb
gene · KG edge: activates ABCB1 (MDR1) - ATP Binding Cassette Subfamily B Member
gene · KG edge: regulates ABCA7 (Redirect)
redirect · KG edge: protects_against acc-chronic-pain
cell_type · KG edge: activates Sleep and Circadian Dysfunction in Alzheimer's Disease
mechanism · Pages share 4 hypotheses

Geniposide for Alzheimer's disease - immune biomarker t
mechanism · Pages share 4 hypotheses APOE4 and Alzheimer's Disease Risk
mechanism · Pages share 4 hypotheses Rotigotine and Rivastigmine Combination Therapy for Alz
clinical · Pages share 4 hypotheses A Phase 3, Randomised, Double-blinded, Placebo-controll
clinical · Pages share 4 hypotheses Synaptic Therapy Alzheimer's Research Trial (START): A
clinical · Pages share 4 hypotheses VILIP-1 and YKL-40 - Alzheimer's Disease Biomarkers
biomarker · Pages share 4 hypotheses Speech and Cognitive Biomarkers for Alzheimer's Disease
biomarker · Pages share 4 hypotheses NPTX1 and NPTXR CSF Markers Predict Alzheimer's Disease
biomarker · Pages share 4 hypotheses ALS Therapeutic Landscape — Programs by Phase and Modal
disease · Pages share 3 hypotheses Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 3 hypotheses

Knowledge Graph (12 edges)

ferroptosis contributes_to osteoarthritis

ferroptosis causes HSC

ferroptosis contributes_to diabetic_nephropathy

ferroptosis regulates lipid_peroxidation

ferroptosis regulates iron metabolism

ferroptosis regulates cysteine metabolism

ferroptosis causes neurodegeneration

ferroptosis causes myocardial ischemia-reperfusion injury

ferroptosis causes tumor cells

ferroptosis causes hemorrhagic transformation

SciDEX — scidex.ai — Dashboard | Atlas